Literature DB >> 25591140

Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis.

Won-Young Kim1, Yejin Mok, Go Woon Kim, Soo-Jin Baek, Young Duk Yun, Sun Ha Jee, Dong Soon Kim.   

Abstract

BACKGROUND: Although the increased risk of coronary artery disease (CAD) in the patients with idiopathic pulmonary fibrosis (IPF) has been reported, there was few detailed information on the risk factors for CAD in IPF. The aim of this study was to investigate the prevalence of CAD in IPF with analysis of other risk factors.
METHODS: The subjects were 460 patients (mean age, 65 years; 79% male; 74% current or ex-smoker) diagnosed as IPF at Asan Medical Center and 1,925 controls matched with age, gender, smoking habits, and date of IPF diagnosis from the cohort of Korean Heart Study. Cardiovascular risk factors and prevalence of CAD in both groups were compared and the incidence of newly developed CAD during follow-up was also analyzed.
RESULTS: IPF group was more diabetic, and control group had a higher proportion of hypertension and hypercholesterolemia. The prevalence of CAD in IPF group (7%) was two times higher than that of control group (3%). Multivariate analysis revealed that age (OR, 1.04; 95% CI, 1.02-1.07), hypertension (OR, 2.13; 95% CI, 1.36-3.33), hypercholesterolemia (OR, 3.85; 95% CI, 2.51-5.88), and IPF (OR, 2.64; 95% CI, 1.68-4.14) were significant risk factors for CAD. During follow-up (median: 2.5 years for IPF and 4.4 years for controls), the incidence of newly diagnosed CAD was higher in the patients with IPF (6.8%) compared to controls (2.8%) (RR, 1.92; 95% CI, 1.08-3.43).
CONCLUSIONS: IPF itself was an independent risk factor for CAD after the adjustment of age, hypertension, diabetes, and hypercholesterolemia.

Entities:  

Mesh:

Year:  2015        PMID: 25591140

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  8 in total

1.  Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis.

Authors:  Miia Kärkkäinen; Hannu-Pekka Kettunen; Hanna Nurmi; Tuomas Selander; Minna Purokivi; Riitta Kaarteenaho
Journal:  Respir Res       Date:  2017-08-22

2.  Idiopathic Pulmonary Fibrosis: A Systemic Disease?

Authors:  Luo Man; Peng Hong
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

Review 3.  Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.

Authors:  Justin M Oldham; Harold R Collard
Journal:  Front Med (Lausanne)       Date:  2017-08-02

Review 4.  Managing comorbidities in idiopathic pulmonary fibrosis.

Authors:  Blair G Fulton; Christopher J Ryerson
Journal:  Int J Gen Med       Date:  2015-09-22

Review 5.  Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.

Authors:  Yutaro Nakamura; Takafumi Suda
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-09-06

6.  Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.

Authors:  Miia Kärkkäinen; Hanna Nurmi; Hannu-Pekka Kettunen; Tuomas Selander; Minna Purokivi; Riitta Kaarteenaho
Journal:  BMC Pulm Med       Date:  2018-05-11       Impact factor: 3.317

7.  Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction.

Authors:  Lorna Elise Clarson; Ram Bajpai; Rebecca Whittle; John Belcher; Alyshah Abdul Sultan; Chun Shing Kwok; Victoria Welsh; Mamas Mamas; Christian D Mallen
Journal:  Heart       Date:  2020-02-29       Impact factor: 5.994

8.  Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review.

Authors:  Le Bai; Li Zhang; Tingyu Pan; Wei Wang; Dian Wang; Cassidy Turner; Xianmei Zhou; Hailang He
Journal:  Respir Res       Date:  2021-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.